Dr. Durr completed his medical school and residency in Ophthalmology at the Université de Montréal. He pursued his training in glaucoma and advanced anterior segment surgery (GAASS) for two years at the University of Toronto under Dr. Ike Ahmed. He currently practices at the Centre Hospitalier de l’Université de Montréal (CHUM) where he treats a variety of glaucoma pathologies, cataracts and complex anterior segment reconstruction.
His research activities touch upon novelties in glaucoma and cataract surgery. Currently, Dr. Durr has several ongoing projects on minimally invasive glaucoma surgery and novel intraocular lenses. He has published numerous articles and two book chapters. At the University, Dr. Durr teaches medical students, residents and clinical fellows. He is the current glaucoma fellowship program director.
Financial disclosure: Dr. Durr has/had an affiliation (financial or otherwise) with a commercial organization:
- Alcon Laboratories
- Allergan, Inc.
- Avisi Technologies Inc.
- Bausch + Lomb
- Glaukos
- Ivantis, Inc.
- Johnson & Johnson Vision
- Nova Eye MD, Inc.
- Santen, Inc.
Sessions auxquelles Georges Durr participe
Vendredi 25 Juin, 2021
Access the Live Meeting: https://www.yourconference.live/COSHow to tackle anterior capsular plaques
Dimanche 27 Juin, 2021
Objectifs d’apprentissage À la fin de la séance, les participants pourront : Reconnaître l’importance d’établir des cibles de PIO chez les patients atteints de glaucomeExpliquer comment surveiller la progression au moyen du champ visuel, des changements constatés par TCO et d’autres outilsSavoir cerner les problèmes d’adhérence chez les patients et quand référer les patients vers des interventions chirurgicales
